Johnson & Johnson’s COVID-19 vaccine may not be as effective as those using mRNA technology, according to a new study Tuesday. The study published by bioRxiv says the 13 million people who received the vaccine may need a second dose, ideally the Pfizer or Moderna vaccine. Although the study was not peer-reviewed or published, the … Read more
AstraZeneca said Monday that advanced study data from a U.S. study on its vaccine shows it is 79% effective at preventing symptomatic COVID-19 and 100% effective at halting serious illness and hospitalization. The first results are among the information AstraZeneca is required to provide to the Food and Drug Administration. An FDA advisory committee will … Read more
As schools re-open across the country, there’s one thing that has not gone away: lockdown drills All of Van Duyn Elementary School in Syracuse, New York, went eerily quiet. On that cold November afternoon in 2019, there was no sound in the school’s hallways except for the echoing of footsteps, going door to door between … Read more
Another COVID-19 vaccine is about to go on sale – a single vaccine from Johnson & Johnson’s pharmaceutical subsidiary Janssen. The company just released an efficacy report based on data from its Phase 3 study that found the new vaccine to be 66% overall effective at preventing moderate to severe incarnations of COVID-19 in those … Read more